Sonoma Pharmaceuticals Inc SNOA Q1 2026 Earnings EPS Slightly Misses Estimates Amid Thin Revenue Disclosures GREE Q1 2025 Earnings NarrowerThanExpected Loss Drives Stock Surge CURR Q3 2025 Earnings Strong EPS Beat Drives Stock Surge HLIT Q1 2026 Earnings Strong EPS Surprise Drives Stock Rally Investors Title Company ITIC Q4 2025 Earnings Strong EPS Performance Amid Limited Visibility REZI Q1 2026 Earnings EPS Beats Estimates Stock Gains 4